Trial Profile
Open-Label Randomized Controlled Trial to Assess the Implementation Effectiveness and Safety of 1% Tenofovir Gel Provision Through Family Planning Services in KwaZulu-Natal, South Africa
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Tenofovir (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 26 Jul 2017 Results (n=133) assessing potential immune mechanism for the relationship between HIV risk and multiple concurrent HPV infections presented at the 9th International AIDS Society Conference on HIV Science
- 27 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 27 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.